Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression

References

• Pastor F, Kolonias D, McNamara JO, 2nd, Gilboa E. Targeting 4-1BB costimulation to disseminated tumor lesions with bi-specific oligonucleotide aptamers. Mol Ther 2011; 19:1878-86; PMID:21829171; http://dx.doi.org/10.1038/mt.2011.145
   PubMed Web of Science ®Google Scholar
• Schrand B, Berezhnoy A, Brenneman R, Williams A, Levay A, Kong LY, Rao G, Zhou S, Heimberger AB, Gilboa E. Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy. Cancer Immunol Res 2014; 2:867-77; PMID:24938283; http://dx.doi.org/10.1158/2326-6066.CIR-14-0007
   PubMed Web of Science ®Google Scholar
• Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O et al. miR-124 Inhibits STAT3 Signaling to Enhance T Cell-Mediated Immune Clearance of Glioma. Cancer Res 2013; 73:3913-26; PMID:23636127; http://dx.doi.org/10.1158/0008-5472.CAN-12-4318
   PubMed Web of Science ®Google Scholar
• Hussain SF, Yang D, Suki D, Aldape K, Grimm E, Heimberger AB. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol 2006; 8:261-79; PMID:16775224; http://dx.doi.org/10.1215/15228517-2006-008
   PubMed Web of Science ®Google Scholar
• Twyman-Saint Victor C, Rech AJ, Maity A, Rengan R, Pauken KE, Stelekati E, Benci JL, Xu B, Dada H, Odorizzi PM et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature 2015; 520:373-7; PMID:25754329; http://dx.doi.org/10.1038/nature14292
   PubMed Web of Science ®Google Scholar
• Holland EC, Varmus HE. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc Natl Acad Sci U S A 1998; 95:1218-23; PMID:9448312; http://dx.doi.org/10.1073/pnas.95.3.1218
   PubMed Web of Science ®Google Scholar
• Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 2001; 15:1913-25; PMID:11485986; http://dx.doi.org/10.1101/gad.903001
   PubMed Web of Science ®Google Scholar
• Shih AH, Dai C, Hu X, Rosenblum MK, Koutcher JA, Holland EC. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res 2004; 64:4783-9; PMID:15256447; http://dx.doi.org/10.1158/0008-5472.CAN-03-3831
   PubMed Web of Science ®Google Scholar
• Doucette TA, Kong LY, Yang Y, Ferguson SD, Yang J, Wei J, Qiao W, Fuller GN, Bhat KP, Aldape K et al. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Neuro Oncol 2012; 14:1136-45; PMID:22753228; http://dx.doi.org/10.1093/neuonc/nos139
   PubMed Web of Science ®Google Scholar
• Berezhnoy A, Cstro I, Levay A, Malek TR, Gilboa E. Aptamer-targeted inhibition of mTOR in T cell enhances antitumor immunity. J Clin Invest 2014; 124(1):188-97; PMID:24292708; http://dx.doi.org/10.1172/JCI69856
   PubMed Web of Science ®Google Scholar
• Ruckman J, Green LS, Beeson J, Waugh S, Gillette WL, Henninger DD, Claesson-Welsh L, Janjić N. 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem 1998; 273:20556-67; PMID:9685413; http://dx.doi.org/10.1074/jbc.
   PubMed Web of Science ®Google Scholar
• Kong LY, Wu AS, Doucette T, Wei J, Priebe W, Fuller GN, Qiao W, Sawaya R, Rao G, Heimberger AB. Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses. Clin Cancer Res 2010; 16:5722-33; PMID:20921210; http://dx.doi.org/10.1158/1078-0432.CCR-10-1693
   PubMed Web of Science ®Google Scholar
• Prinz M, Priller J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci 2014; 15:300-12; PMID:24713688; http://dx.doi.org/10.1038/nrn3722
   PubMed Web of Science ®Google Scholar
• Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen L, Xiao HL, Wang B, Yi L, Wang QL et al. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J Immunol 2012; 189:444-53; PMID:22664874; http://dx.doi.org/10.4049/jimmunol.1103248
   PubMed Web of Science ®Google Scholar
• Schrand B, Berezhnoy A, Brenneman R, Williams A, Levay A, Gilboa E. Reducing toxicity of 4-1BB costimulation: targeting 4-1BB ligands to the tumor stroma with bi-specific aptamer conjugates. Oncoimmunology 2015; 4:e970918; PMID:25949891; http://dx.doi.org/10.4161/21624011.2014.970918
   PubMed Web of Science ®Google Scholar
• Yue C, Shen S, Deng J, Priceman SJ, Li W, Huang A, Yu H. STAT3 in CD8+ T cells inhibits their tumor accumulation by down-regulating CXCR3/CXCL10 axis. Cancer Immunol Res 2015; 3(8):864-70; PMID:26025380; http://dx.doi.org/10.1158/2326-6066.CIR-15-0014
   PubMed Web of Science ®Google Scholar
• Wu A, Wei J, Kong LY, Wang Y, Priebe W, Qiao W, Sawaya R, Heimberger AB. Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol 2010; 12:1113-25; PMID:20667896; http://dx.doi.org/10.1093/neuonc/noq082
   PubMed Web of Science ®Google Scholar
• Doucette TA, Rao G, Rao A, Shen L, Aldape K, Wei J, Dziurzynski K, Gilbert M, Heimberger AB. Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas. Cancer Immunol Res 2013; 1:112-22; PMID:24409449; http://dx.doi.org/10.1158/2326-6066.CIR-13-0028
   PubMed Web of Science ®Google Scholar
• Keefe AD, Pai S, Ellington A. Aptamers as therapeutics. Nat Rev Drug Discov 2010; 9:537-50; PMID:20592747; http://dx.doi.org/10.1038/nrd3141
   PubMed Web of Science ®Google Scholar